Literature DB >> 11104565

Elevated expression of thyroid hormone receptor alpha 2 (c-erb A- alpha 2) in nasopharyngeal carcinoma.

J W Lee1, C L Chen, B T Juang, J Y Chen, C S Yang, S L Doong.   

Abstract

Differential display was used to identify genes differentially expressed between cultured normal nasal epithelial cells and nasopharyngeal carcinoma (NPC) cell lines. A 130 bp cDNA fragment showing homology with thyroid hormone receptor alpha2 (TR-alpha2 or c-erb A-alpha2) was identified in NPC cell lines. Northern blot analysis using the 130 bp cDNA fragment and a TR-alpha2 specific cDNA containing part of the coding region as probes, we were able to detect a 2.7 kb transcript corresponding to that of TR-alpha2 in NPC cell lines but not in normal nasal epithelial cells. RNA in situ hybridization was used to detect TR-alpha2 expression in clinical biopsies obtained from NPC patients and non-tumour controls. TR-alpha2 mRNA was detected in 1 out of 24 (4.2%) normal nasopharynx epithelium biopsies, in 5 out of 27 (18.5%) primary and 15 out of 24 (62.5%) recurrent tumours. The positive rate of TR-alpha2 expression in recurrent NPC biopsies was significantly higher than that in normal nasopharynx epithelium (P<0.00001). The relevance of the elevated expression of TR-alpha2 in the pathogenesis process of NPC was discussed. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104565      PMCID: PMC2363452          DOI: 10.1054/bjoc.2000.1505

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  [Primary study of differentially expressed cDNA sequences in cell line HNE1 of human nasopharyngeal carcinoma by cDNA representational difference analysis].

Authors:  F Zhan; N Jiang; L Cao; L Deng; G Tan; M Zhou; Y Xie; G Li
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  1998-12-10

2.  Identification of genes differentially expressed in nasopharyngeal carcinoma by messenger RNA differential display.

Authors:  L F Fung; P W Yuen; W Wei; H S Kwan; S W Tsao
Journal:  Int J Oncol       Date:  1998-07       Impact factor: 5.650

Review 3.  Etiology of nasopharyngeal carcinoma: a review.

Authors:  A Hildesheim; P H Levine
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

4.  Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization.

Authors:  Y J Chen; J Y Ko; P J Chen; C H Shu; M T Hsu; S F Tsai; C H Lin
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

5.  Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation.

Authors:  A B Hui; K W Lo; S F Leung; P Teo; M K Fung; K F To; N Wong; P H Choi; J C Lee; D P Huang
Journal:  Int J Cancer       Date:  1999-08-12       Impact factor: 7.396

6.  Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells.

Authors:  K H Lin; H Y Shieh; S L Chen; H C Hsu
Journal:  Mol Carcinog       Date:  1999-09       Impact factor: 4.784

7.  Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma.

Authors:  L F Hu; G Eiriksdottir; T Lebedeva; I Kholodniouk; A Alimov; F Chen; Y Luo; E R Zabarovsky; S Ingvarsson; G Klein; I Ernberg
Journal:  Genes Chromosomes Cancer       Date:  1996-10       Impact factor: 5.006

8.  The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry.

Authors:  M J Porter; J K Field; S F Leung; D Lo; J C Lee; D A Spandidos; C A van Hasselt
Journal:  Acta Otolaryngol       Date:  1994-01       Impact factor: 1.494

9.  No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.

Authors:  Y Sun; A Hildesheim; A E Lanier; Y Cao; K T Yao; N Raab-Traub; C S Yang
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

10.  Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.

Authors:  A Mutirangura; C Tanunyutthawongese; W Pornthanakasem; V Kerekhanjanarong; V Sriuranpong; S Yenrudi; P Supiyaphun; N Voravud
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  2 in total

Review 1.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

2.  Hypothyroidism enhances tumor invasiveness and metastasis development.

Authors:  Olaia Martínez-Iglesias; Susana García-Silva; Javier Regadera; Ana Aranda
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.